BioXcel Therapeutics, Inc. Email Format

Biotechnology ResearchConnecticut, United States51-200 Employees

BioXcel Therapeutics, Inc. is a New Haven-based biopharmaceutical company focused on developing medicines for neurological conditions, guided by artificial intelligence. It operates within the biotechnology research field and seeks to advance therapies in neuroscience, with some activity noted in immuno-oncology. The company is headquartered in New Haven, Connecticut, placing it in a mid-sized, clinically oriented life sciences community.

The organization targets healthcare providers and patients dealing with neurological disorders, aiming to offer therapies that address unmet needs in neuroscience. In 2024, BioXcel Therapeutics announced plans for a pivotal Phase 3 trial of BXCL501 to treat agitation associated with Alzheimer's dementia, reflecting its ongoing clinical development program.

Sign up for free to view info

Company overview Employee directory